Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Glaxosmithkline Pharmaceuticals LtdIndustry : Pharmaceuticals - Multinational
BSE Code:500660NSE Symbol: GLAXOP/E(TTM):55.81
ISIN Demat:INE159A01016Div & Yield %:1.53EPS(TTM):37.52
Book Value(Rs):91.3566062Market Cap ( Cr.):35471.08Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 3216.343217.512920.483224.683128.532895.88
Excise Duty0.000.000.000.000.0024.19
Net Sales3216.343217.512920.483224.683128.532871.69
Other Income 114.961423.27217.71624.37149.5671.32
Stock Adjustments -67.25-13.8326.1235.43-25.5757.94
Total Income3264.054626.953164.313884.483252.523000.95
EXPENDITURE :      
Raw Materials 1182.781281.911275.491343.301327.961298.69
Power & Fuel Cost29.6027.8326.0833.3627.9426.44
Employee Cost 594.99610.23616.16628.55537.20523.40
Other Manufacturing Expenses 99.05120.14110.59107.88115.19110.55
Selling and Administration Expenses 370.30343.57242.00376.68381.32357.82
Miscellaneous Expenses 84.3285.69287.75983.19150.08104.29
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure2361.042469.382558.073472.962539.682421.18
Operating Profit903.012157.57606.24411.52712.85579.76
Interest 1.811.993.536.340.550.19
Gross Profit901.202155.58602.71405.18712.30579.57
Depreciation65.7768.1978.6082.6848.5937.99
Profit Before Tax835.432087.39524.11322.50663.71541.58
Tax246.05407.36158.67260.17192.82204.34
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-18.37-10.497.87-47.7245.52-14.74
Reported Net Profit607.751690.53357.57110.05425.36351.99
Extraordinary Items 21.0511.18-117.79-87.094.049.57
Adjusted Net Profit586.701679.35475.36197.14421.32342.42
Adjst. below Net Profit -17.08-11.050.00-73.62-64.12-51.73
P & L Balance brought forward1745.02562.71882.771177.991113.211067.06
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 1524.66508.22677.62338.81296.46254.11
P & L Balance carried down811.031733.98562.71875.621177.991113.21
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %320.00900.00300.00400.00200.00350.00
Earnings Per Share-Unit Curr35.8899.7921.116.5025.1141.56
Earnings Per Share(Adj)-Unit Curr35.8899.7921.116.5025.1120.78
Book Value-Unit Curr103.48158.0688.37108.62126.47245.56